Phathom Pharmaceuticals appoints Basta as President, CEO

Phathom Pharmaceuticals (PHAT) announced that Steven Basta has been appointed President and Chief Executive Officer and a member of the Board of Directors, effective immediately. Basta succeeds Terrie Curran, who is stepping down as President and CEO and as a member of the Board of Directors for personal reasons.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue